ACA

Arcosa, Inc.
$144.39
-0.26 (-0.18%)
Mkt Cap 7.10B
Volume 622,743
52W Range 81.91-146.92
Sector Industrials
Beta 1.04
EPS (TTM) 4.54
P/E Ratio 31.86
Revenue (TTM) 2.82B
Rev Growth (5Y) +8.3%
EPS Growth (5Y) +14.1%
AlphaVal · Fair Value
What we estimate one share is worth
$54.87
Overvalued strong signal
163.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Platform & Compounding FCF
65.2 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 2.88B 2.57B 2.31B 2.24B 2.04B 1.94B 1.74B 1.46B 1.46B 1.70B 2.14B
Net Income 208.40M 93.70M 159.20M 245.80M 69.60M 106.60M 113.30M 75.70M 89.70M 123.00M 135.00M
EPS 4.25 1.92 3.27 5.08 1.44 2.20 2.37 1.55 1.84 2.52 2.77
Free Cash Flow 175.50M 312.30M 57.50M 36.30M 81.40M 177.80M 273.40M 73.70M 79.60M 143.00M 204.40M
FCF / Share 3.59 6.43 1.19 0.75 1.69 3.70 5.71 1.51 1.63 2.93 4.19
Operating CF 341.10M 502.00M 261.00M 174.30M 166.50M 259.90M 358.80M 118.50M 162.00M 227.80M 293.20M
Total Assets 4.87B 4.92B 3.58B 3.34B 3.19B 2.65B 2.30B 2.17B 1.60B 1.53B N/A
Total Debt 1.52B 1.75B 606.80M 587.20M 703.40M 254.50M 130.60M 185.50M 500,000 0 N/A
Cash & Equiv 214.60M 187.30M 104.80M 160.40M 72.90M 95.80M 240.40M 99.40M 6.80M 14.00M N/A
Book Value 2.62B 2.43B 2.33B 2.18B 1.95B 1.89B 1.79B 1.68B 1.41B 1.34B N/A
Return on Equity 0.08 0.04 0.07 0.11 0.04 0.06 0.06 0.04 0.06 0.09 N/A
ACA News
Do Options Traders Know Something About Arcosa Stock We Don't?
Jul 21, 2026 06:06 AM · zacks.com
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders
Jul 06, 2026 09:59 AM · globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
Jul 06, 2026 08:17 AM · globenewswire.com
Shareholder Alert: Ademi LLP investigates whether Arcosa, Inc. is obtaining a Fair Price for Public Shareholders
Jul 02, 2026 01:19 AM · globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
Jun 30, 2026 09:13 AM · globenewswire.com
Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA
Jun 24, 2026 11:00 AM · gurufocus.com
Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA
Jun 24, 2026 10:17 AM · businesswire.com
Is CRH's $8.5 Billion Arcosa Acquisition a Game Changer?
Jun 23, 2026 06:51 AM · zacks.com
ACA Group Expands U.S. Footprint with New Durham, N.C. Office
Jun 23, 2026 04:00 AM · businesswire.com
Arcosa Inc (ACA) Stock Up 6.7% but GF Value Says Overvalued -- GF Score: 78/100
Jun 22, 2026 04:11 PM · gurufocus.com